Literature DB >> 18251935

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement.

S Warnakulasuriya1, J Reibel, J Bouquot, E Dabelsteen.   

Abstract

At a workshop coordinated by the WHO Collaborating Centre for Oral Cancer and Precancer in the United Kingdom issues related to potentially malignant disorders of the oral cavity were discussed by an expert group. The consensus views of the Working Group are presented in a series of papers. In this report, we review the oral epithelial dysplasia classification systems. The three classification schemes [oral epithelial dysplasia scoring system, squamous intraepithelial neoplasia and Ljubljana classification] were presented and the Working Group recommended epithelial dysplasia grading for routine use. Although most oral pathologists possibly recognize and accept the criteria for grading epithelial dysplasia, firstly based on architectural features and then of cytology, there is great variability in their interpretation of the presence, degree and significance of the individual criteria. Several studies have shown great interexaminer and intraexaminer variability in the assessment of the presence or absence and the grade of oral epithelial dysplasia. The Working Group considered the two class classification (no/questionable/ mild - low risk; moderate or severe - implying high risk) and was of the view that reducing the number of choices from 3 to 2 may increase the likelihood of agreement between pathologists. The utility of this need to be tested in future studies. The variables that are likely to affect oral epithelial dysplasia scoring were discussed and are outlined here; these need to be researched in longitudinal studies to explore the biological significance of a low-risk or high-risk dysplasia.

Entities:  

Mesh:

Year:  2008        PMID: 18251935     DOI: 10.1111/j.1600-0714.2007.00584.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  150 in total

1.  Oral premalignant lesions.

Authors:  Teruo Amagasa
Journal:  Int J Clin Oncol       Date:  2011-01-07       Impact factor: 3.402

2.  Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials.

Authors:  Paul M Speight; Timothy J Abram; Pierre N Floriano; Robert James; Julie Vick; Martin H Thornhill; Craig Murdoch; Christine Freeman; Anne M Hegarty; Katy D'Apice; A Ross Kerr; Joan Phelan; Patricia Corby; Ismael Khouly; Nadarajah Vigneswaran; Jerry Bouquot; Nagi M Demian; Y Etan Weinstock; Spencer W Redding; Stephanie Rowan; Chih-Ko Yeh; H Stan McGuff; Frank R Miller; John T McDevitt
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-06-17

3.  Use of endoscopy with narrow-band imaging system in detecting squamous cell carcinoma in oral chronic non-healing ulcers.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Cheng Hwang; Tai-An Chen
Journal:  Clin Oral Investig       Date:  2013-07-09       Impact factor: 3.573

4.  Early Detection of Oral Squamous Cell Carcinoma (OSCC) - Role of Genetics: A Literature Review.

Authors:  C Seethalakshmi
Journal:  J Clin Diagn Res       Date:  2013-08-01

5.  Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia.

Authors:  Karthik Krishnan; Sivapathasundharam Balasundaram
Journal:  J Clin Diagn Res       Date:  2017-03-01

6.  Impact of Age on Disease Progression and Microenvironment in Oral Cancer.

Authors:  V K Vincent-Chong; H DeJong; L J Rich; A Patti; M Merzianu; P A Hershberger; M Seshadri
Journal:  J Dent Res       Date:  2018-05-11       Impact factor: 6.116

7.  Differentiated dysplasia is a frequent precursor or associated lesion in invasive squamous cell carcinoma of the oral cavity and pharynx.

Authors:  Ruza Arsenic; Michael O Kurrer
Journal:  Virchows Arch       Date:  2013-04-16       Impact factor: 4.064

8.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

9.  A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Authors:  Xiao-Han Tang; Martin Albert; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

10.  Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system.

Authors:  Marta Rabello Piva; Lélia Batista DE Souza; Paulo Ricardo Saquete Martins-Filho; Rosilene Calazans Soares; Thiago DE Santana Santos; Emanuel Sávio DE Souza Andrade
Journal:  Oncol Lett       Date:  2011-08-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.